↓ Skip to Main Content
Thasso
Thasso the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs

search: thasso

Log in

Main Navigation

  • english
    • english
    • français
    • deutsch
    • italiano
    • español
    • português
  • thasso
  • thasso post
  • thasso toolbox
    • theragenomics: useful links
    • theragenomics: biomarkers
    • theragenomics: companion tests
    • theragenomics: drug labels with annotated information
    • theragenomics: drugs and genes
    • theragenomics: the world of alleles
    • theragenomics: allele-related guideline information
    • drug interactions
    • drug information
    • drug adverse reactions
    • drugs: risk evaluation and mitigation strategies (REMS)
    • theragenomics: videos
  • thasso academy
    • health authorities
    • patient & consumer health
    • public domain
      • Swiss Academy of Medical Sciences
      • EUPATI The European Patients’ Academy on Therapeutic Innovation
    • companies
    • products
    • about
  • thasso community
    • thasso: simple chat
    • thasso: video chat
    • theragenomics: survey at thasso
      • survey participants
    • forum
      • patient groups / subgroups
      • group
      • lounge
      • events
      • gallery
  • thasso: about
    • vision
    • background
    • the apomediary patient
    • contact
    • disclaimers
    • policies
  • donations
    • thasso – thank you
    • Donation Confirmation

Tag: Bradycardia

Could the HCV drug sofosbuvir be cardiotoxic? Is there a role in genetic predisposition?

By Joseph Gut - thasso Posted on April 4, 2015 Posted in Adverse Drug Reaction [ADR], Genetic Predisposition, Thasso Post, Theragenomic Medicine Tagged with Amiodarone, Bradycardia, Carboxylesterase 1 (CES-1), CES-1 rs2244613 Allelic Variant, Genetic Predisposition, Ledipasvir/Sofosbuvir (Harvoni), Sofosbuvir [Sovaldi], The Institute for Safe Medical Practice (ISMP)
Could the HCV drug sofosbuvir be cardiotoxic? Is there a role in genetic predisposition?

April 4, 2015 – There’s nothing like the real world to shed light on the safety of new drugs and devices. Clinical trials may be the best way to compare treatments, but patients enrolled in trials are carefully selected and …

Could the HCV drug sofosbuvir be cardiotoxic? Is there a role in genetic predisposition? Read more »

Footer Menu

  • english
  • thasso
  • thasso post
  • thasso toolbox
  • thasso academy
  • thasso community
  • thasso: about
  • donations
Copyright © 2025 Thasso | Powered by Responsive Theme